Diabetes Australia and OPSM Partner for Better Eye Health 13 July 2016 Diabetes Australia and OPSM have partnered to raise awareness of diabetes and eye health in Australia. Each day 280 Australians develop diabetes – that’s one every five minutes. Without the proper care, diabetes can lead to diabetes-related complications, such as eye-disease and potentially vision loss. Proactive, consistent diabetes management and care, as well as early detection, can help prevent or delay the onset of these diabetes-related complications. OPSM are leaders in the eye care and eyewear space and are dedicated to providing life-changing eye care for Australians. OPSM works with local communities to help improve vision while promoting the critical importance of good eye health. Together, we hope to: Raise awareness of the links between diabetes and eye health. We will raise awareness of this important issue so that we can help reduce the incidence of diabetes-related eye disease. Promote prevention and early detection of diabetes-related eye disease, such as diabetic retinopathy. Diabetic retinopathy is the leading cause of blindness in working age adults. Early detection and treatment can prevent up to 98 per cent of severe vision loss. Enhance diabetes and eye health education amongst people living with diabetes and healthcare professionals. OPSM optometrists work collaboratively with allied health care professionals to ensure optimal health and wellbeing for patients. Our intent is to form stronger care networks and encourage robust and informed dialogue between people living with diabetes and healthcare professionals. Always speak to your healthcare professional to help manage your diabetes. Eye tests can be arranged through an optometrist visit Diabetes Australia is the national body for all people affected by all types of diabetes and those at risk. Diabetes Australia works with people with diabetes, families and carers, healthcare professionals, researchers and state governments to help reduce the impact of diabetes on the Australian community. Written by: Diabetes Australia
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading